Clinical features and prognoses of acute transverse myelitis in patients with systemic lupus erythematosus.
Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis.
Reduction or cessation of antiviral agents in hepatitis B virus carriers treated with biologic agents.
Safety of the concomitant use of methotrexate and a prophylactic dose of trimethoprim-sulfamethoxazole.
The risk of herpes zoster in patients with ankylosing spondylitis: Analysis of the Korean National Health Insurance Service - Sample cohort database.
CD14(+) Cells with the Phenotype of Infiltrated Monocytes Consist of Distinct Populations Characterized by Anti-inflammatory as well as Pro-inflammatory Activity in Gouty Arthritis.
Ileocolonoscopic findings in patients with ankylosing spondylitis: a single center retrospective study.
Interleukin-32 Gamma Stimulates Bone Formation by Increasing miR-29a in Osteoblastic Cells and Prevents the Development of Osteoporosis.
Longterm Outcomes of Renal Artery Involvement in Takayasu Arteritis.
Monthly Oral Ibandronate Reduces Bone Loss in Korean Women With Rheumatoid Arthritis and Osteopenia Receiving Long-term Glucocorticoids: A 48-week Double-blinded Randomized Placebo-controlled Investigator-initiated Trial.
Nontuberculous mycobacterial infection in rheumatoid arthritis patients: a single-center experience in South Korea.
Risk of Colchicine-Associated Myopathy in Gout: Influence of Concomitant Use of Statin.
The Reply.
Adequacy of initiating TNF antagonists within 3 weeks of starting latent tuberculosis infection treatment in patients with immune-mediated inflammatory diseases.
Febuxostat in Hyperuricemic Patients With Advanced CKD.
Late-onset IgA vasculitis in adult patients exhibits distinct clinical characteristics and outcomes.
Neutrophil-to-lymphocyte ratio is a reliable marker of treatment response in rheumatoid arthritis patients during tocilizumab therapy.
Safety of tumor necrosis factor inhibitor therapy in patients with a prior malignancy.
Clinical outcomes of hydronephrosis in patients with systemic lupus erythematosus.
Comparison of LTBI treatment regimens for patients receiving anti-tumour necrosis factor therapy.
Factors related to outcomes in lupus-related protein-losing enteropathy
High level of interleukin-32 gamma in the joint of ankylosing spondylitis is associated with osteoblast differentiation.
Interleukin-33 acts as a transcriptional repressor and extracellular cytokine in fibroblast-like synoviocytes in patients with rheumatoid arthritis
Mortality in patients with rheumatoid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent.
Pericentral hydroxychloroquine retinopathy in Korean patients.
Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis.
Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay
Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
Frequency of immunoglobulin G4-related aortitis in cases with aortic resection and their clinical characteristics compared to other aortitises.
Lupus enteritis: clinical characteristics and predictive factors for recurrence.
Mycobacterial diseases developed during anti-tumour necrosis factor-α therapy
Neuro-beh?et's disease in South Korea: clinical characteristics and treatment response.
Outcome of takayasu arteritis with inactive disease at diagnosis: the extent of vascular involvement as a predictor of activation.
Role of protein phosphatase magnesium-dependent 1A and anti-protein phosphatase magnesium-dependent 1A autoantibodies in ankylosing spondylitis.
Safety of resuming tumour necrosis factor inhibitors in patients who developed tuberculosis as a complication of previous TNF inhibitors.
TNF-α confers resistance to Fas-mediated apoptosis in rheumatoid arthritis through the induction of soluble Fas.
The 'either test positive' strategy for latent tuberculous infection before anti-tumour necrosis factor treatment
Clinical features and prognosis in 82 patients with adult-onset Still's disease.
Incidence of tuberculosis among anti-tumor necrosis factor users in patients with a previous history of tuberculosis
The effect of various disease-modifying anti-rheumatic drugs on the suppressive function of CD4⁺CD25⁺ regulatory T cells.
Chlamydophila pneumoniae inhibits corticosteroid-induced suppression of metalloproteinase-9 and tissue inhibitor metalloproteinase-1 secretion by human peripheral blood mononuclear cells
Combined use of a TST and the T-SPOT?.TB assay for latent tuberculosis infection diagnosis before anti-TNF-
SUNGYESA
